Timeline: When Bad Research Changes Public Health Strategy
Timeline: When Bad Research Changes Public Health Strategy
Illinois-based Surgisphere Corporation had a brief moment in the limelight this year following its infamous study of hydroxychloroquine. But the impact of the company’s deception reverberated across world.
Timeline: When Bad Research Changes Public Health Strategy
Timeline: When Bad Research Changes Public Health Strategy

Illinois-based Surgisphere Corporation had a brief moment in the limelight this year following its infamous study of hydroxychloroquine. But the impact of the company’s deception reverberated across world.

Illinois-based Surgisphere Corporation had a brief moment in the limelight this year following its infamous study of hydroxychloroquine. But the impact of the company’s deception reverberated across world.

data manipulation
The Surgisphere Scandal: What Went Wrong?
The Surgisphere Scandal: What Went Wrong?
Catherine Offord | Oct 1, 2020
The high-profile retractions of two COVID-19 studies stunned the scientific community earlier this year and prompted calls for reviews of how science is conducted, published, and acted upon. The warning signs had been there all along.
KU Leuven Investigates Whether Stem Cell Scientist Falsified Data
KU Leuven Investigates Whether Stem Cell Scientist Falsified Data
Catherine Offord | Dec 10, 2019
Papers from Catherine Verfaillie’s lab have been drawing fire for years.
Leaders of AveXis Out Over Doctored Gene Therapy Data
Leaders of AveXis Out Over Doctored Gene Therapy Data
Kerry Grens | Aug 14, 2019
Novartis, which bought the biotech firm in 2018, announced that the company’s top scientists have left, and news reports say it’s because they were involved in using manipulated data to get the gene therapy Zolgensma approved.
Some Data Backing Novartis Gene-Therapy Approval Manipulated: FDA
Some Data Backing Novartis Gene-Therapy Approval Manipulated: FDA
Nicoletta Lanese | Aug 7, 2019
The agency is now evaluating the implications of the corrupted data behind Zolgensma and whether to “take action” against the pharmaceutical company.
Dozens of Retractions Requested for Heart Stem Cell Studies
Dozens of Retractions Requested for Heart Stem Cell Studies
Ashley P. Taylor | Oct 15, 2018
Harvard and Brigham and Women’s Hospital disavow the work by former faculty member Piero Anversa.
Report: Former CNRS President Guilty of Fraud
Report: Former CNRS President Guilty of Fraud
Jef Akst | Oct 15, 2018
Anne Peyroche, who was removed as interim head of France’s National Center for Scientific Research in January, committed scientific misconduct, according to the French Academy of Sciences.
Two Plant Biologists Penalized by CNRS in France
Two Plant Biologists Penalized by CNRS in France
Jef Akst | Oct 3, 2018
Olivier Voinnet and Patrice Dunoyer face consequences for misconduct that led to the retractions of numerous high-profile papers.
Third Retraction for Harvard Cancer Biologist
Third Retraction for Harvard Cancer Biologist
Katarina Zimmer | Jul 25, 2018
The move follows two major corrections to a 2011 Nature paper, in which researchers demonstrated that a natural compound selectively kills cancer cells.
Emails Reveal Questionable Practices by Cornell Food Scientist and His Coauthors
Emails Reveal Questionable Practices by Cornell Food Scientist and His Coauthors
Shawna Williams | Feb 26, 2018
The correspondence points to routine data-massaging at a high-profile lab.